1-6 of 6
Mei K. La
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children’s Oncology Group Study 1991

Yousif Matloub, MD, Bruce C. Bostrom, MD, Stephen P. Hunger, MD, Anne L Angiolillo, MD, Catherine Cole, MD, Blythe Thomson, MD, Meenakshi Devidas, PhD, Nyla A. Heerema, PhD, Mei K La, Patrick J. Buckley, MD, PhD, William L. Carroll, MD, Naomi Winick, MD, Harland Sather, PhD, James B Nachman, MD, Paul S. Gaynon, MD
Journal: Blood
Blood (2008) 112 (11): 9.
https://doi.org/10.1182/blood.V112.11.9.9
Published: 2008
Journal Articles

Survival after Relapse in Higher Risk Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents Is Independent of Prior Treatment Intensity: A Report from the Children’s Oncology Group (COG).

David Robert Freyer, DO, Nita L. Seibel, MD, Mei K La, MS, Meenakshi Devidas, PhD, William L. Carroll, MD, Stephen P. Hunger, MD, Paul S. Gaynon, MD
Journal: Blood
Blood (2008) 112 (11): 917.
https://doi.org/10.1182/blood.V112.11.917.917
Published: 2008
Journal Articles

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Clinical Trials & Observations
Nita L. Seibel, Peter G. Steinherz, Harland N. Sather, James B. Nachman, Cynthia DeLaat, Lawrence J. Ettinger, David R. Freyer, Leonard A. Mattano, Jr, Caroline A. Hastings, Charles M. Rubin, Kathy Bertolone, Janet L. Franklin, Nyla A. Heerema, Torrey L. Mitchell, Allan F. Pyesmany, Mei K. La, Cheryl Edens, Paul S. Gaynon
Journal: Blood
Blood (2008) 111 (5): 2548–2555.
https://doi.org/10.1182/blood-2007-02-070342
Published: 2008
Journal Articles

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Robert Cho, MD, Linda C. Stork, MD, Paul S. Gaynon, MD, Harland N. Sather, PhD, Mei K. La, MS, Raymond J. Hutchinson, MD
Journal: Blood
Blood (2005) 106 (11): 867.
https://doi.org/10.1182/blood.V106.11.867.867
Published: 2005
Journal Articles

Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952.

Suman Malempati, MD, Paul S. Gaynon, MD, Harland Sather, PhD, Mei K. La, MS, Linda C. Stork, MD
Journal: Blood
Blood (2004) 104 (11): 520.
https://doi.org/10.1182/blood.V104.11.520.520
Published: 2004
Journal Articles

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Clinical Trials & Observations
Bruce C. Bostrom, Martha R. Sensel, Harland N. Sather, Paul S. Gaynon, Mei K. La, Katherine Johnston, Gary R. Erdmann, Stuart Gold, Nyla A. Heerema, Raymond J. Hutchinson, Arthur J. Provisor, Michael E. Trigg
Journal: Blood
Blood (2003) 101 (10): 3809–3817.
https://doi.org/10.1182/blood-2002-08-2454
Published: 2003